{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-041537","form_type":"8-K","ticker":"AIM","cik":"0000946644","company_name":"AIM ImmunoTech Inc.","filed_at":"2026-09-04T20:05:22+00:00","discovered_at":"2026-09-04T20:07:00.355600+00:00","generated_at":"2026-09-04T20:07:41.759506+00:00","sec_items":["1.01","1.02","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"AIM ImmunoTech converts $1.22M promissory note into 5.07M shares, note satisfied","bullets":["Converted ~$1,224,341 of Feb 16, 2024 promissory note into 5,065,840 shares at avg $0.24/share.","Promissory note (original principal $3,301,250) fully satisfied as of Sept 3, 2026; no amounts owing.","Exchange shares issued under Section 3(a)(9) exemption; no commission or remuneration paid.","Stockholders approved conversion at July 15, 2026 special meeting per NYSE American rules.","Shares to be free-trading under Rule 144; holding period tacks to Feb 16, 2024 original note date."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-041537","json":"https://secwatch.observer/filing/0001493152-26-041537.json","markdown":"https://secwatch.observer/filing/0001493152-26-041537.md","text":"https://secwatch.observer/filing/0001493152-26-041537.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/946644/000149315226041537/0001493152-26-041537-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/946644/000149315226041537/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-04T20:07:41.759506+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}